Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures
Clinical trial NCT01832038 · COMPLETED
Trial details
- NCT number
- NCT01832038
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-26
- Primary completion
- 2019-07-31
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.